Daiichi Sankyo has signed a collaborative agreement with three technology partners to improve the detection and diagnosis of atrial fibrillation (AF) in the UK.
As part of the collaboration with FibriCheck, neoHealthTech and Capitol Medicare, Daiichi will work to offer innovative digital solutions for patients and clinicians in the management of AF.
The partnership will also focus on addressing the increased need for at-home diagnosis as a result of the COVID-19 pandemic.
Sankyo Automation We have been one of the most advanced leaders in cam driven index technology since 1987. To this day, Sankyo continues to develop renowned, original motion control technology. Good Afternoon, I have a Sankyo digital clock model # 401 which was running fine but about a week ago it started to make a humming noise. Today the noise was real loud & the second drum was not turning. When I opened it up the what looks to be a solinoid was hot and smelt burnt.
At the moment, there is no remote end-to-end AF detection and diagnosis pathway within the NHS, according to Daiichi.
The new partnership will offer at-risk patients access to at-home technologies, including a smartphone application and wearable echocardiogram monitoring device, that can remotely monitor and enable the detection and diagnosis of AF.
“These technologies offer significant opportunities to drive earlier detection and diagnosis of AF, which as a result, supports efforts to prevent AF-related cardiovascular events,” said Manuel Reiberg, managing director at Daiichi Sankyo UK.
“This cross-sector collaboration is a central part of our commitment to provide our healthcare partners with innovative, sustainable solutions, and we look forward to analysing the impact these projects will have on patient outcomes,” he added.
Through the collaboration, various local integrated projects will be delivered in pilot areas at the Primary Care Network (PCN) level across the UK throughout 2021 and 2022.
These will provide local data on both the efficacy and outcomes of the programme, Daiichi said in a statement.
This is an auto-generated feed from Pharma Times. Views expressed in this article are of Pharma Times, and Pharma Discoveries is not responsible for any claims made in this story.
Beware of counterfeit manufacturers of Sankyo Oilless cam units. Sankyo Oilless Ind (USA) does not license or approve any other company to manufacture our cam units in the United States. In the past year we have seen many 'knock-off' versions of our cam units appear in the United States. At any time if you have any questions please contact us immediately.
Sankyo Digital 401
As a leader in the field of oilless technology, Sankyo Oilless Industry Inc. supplies
a range of products that has gained an excellent reputation for reliability and performance.
Sankyo Digital Clock Model 401
You can search for products.
CAD data downloading is also available for registered members.